Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
COPYRIGHT PULSUS GROUP INC. – DO NOT COPY CANADIAN PAEDIATRIC SOCIETY – 89th Annual Conference Common Dermatological Problems in the Paediatric Office James Bergman, MD FRCPC Clinical Assistant Professor Department of Dermatology and Skin Science University of British Columbia, Vancouver, British Columbia Miriam Weinstein, MD FRCPC Associate Professor of Medicine and Pediatrics University of Toronto Co-Chief, Dermatology Hospital For Sick Children, Toronto, Ontario Many common dermatological problems can safely be treated and followed up by the paediatrician, although referral is advised when a diagnosis is in doubt, treatment may be complicated or the skin condition suggests a more serious syndrome. Numerous skin conditions encountered in everyday paediatric practice can produce uncertainty as to diagnosis and optimal management. Close attention to one or two key distinguishing features can typically help the clinician identify the problem or distinguish a benign condition from a more serious entity that may present with similar characteristics. New medications and modalities can replace or supplement classic treatments for several common problems. Hemangiomas Hemangiomas are caused by vascular proliferation. They typically grow for the first six to 12 months of life, then stabilize and and then slowly involute. “They may not completely go away. There may be some residual effects such as telangiectases or fibrofatty tissue,” Dr Bergman cautioned. Although most hemangiomas are benign, aggressive therapy is sometimes warranted. For example, large nasal hemangiomas may have severe cosmetic effects through destruction of cartilage. A hemangioma in a beard distribution may indicate laryngeal involvement that can effect the airway and can be life threatening if bleeding occurs. A lesion in the groin region may be prone to breakdown, ulceration, infection and scarring. “When they are large, perineal heman- giomas can be associated with gastrointestinal or genitourinary abnormalities,” noted Dr Bergman. A lesion near the eye may impede vision or produce pressure effects, so early treatment and/or referral to an ophthalmologist is appropriate. A large facial hemangioma may also raise suspicion of PHACES (Posterior fossa brain abnormality/Hemangioma/Arterial cerebrovascular abnormalities/Cardiac anomalies/Eye problems/Sternal defects) syndrome, which requires an extensive diagnostic workup. A patient with numerous hemangiomas has an increased risk of systemic hemangiomatosis. The risk of this is more significantly increased if the patient has more than five lesions, Dr Bergman indicated. When the hemangioma is life threatening or has serious functional implications then most paediatric dermatologists now use oral propanolol instead of high dose oral steroids. This strategy alleviates parents’ and physicians’ anxiety over the side effects of high-dose oral steroids. Propanolol appears to be safe, but given the drug’s known mechanisms of action and reports of side effects, its use at this point should be undertaken by someone familiar with the treatment of hemangiomas with propanolol (1,2). When a hemangioma engenders cosmetic, psychosocial or less serious medical concern, then treatment with topical beta blocker can be effective (3). Timolol is available commercially at 0.5% as an ophthalmological preparation. Dr Bergman indicated that in his practice he has a pharmacist compound timolol into a 2% gel which may increase the effect and allows easier application given the thicker consistency. In his experience, topical 2% timolol can work quite well but this depends on the thickness of the hemangioma and how early the lesion is treated. The risks of side effects are much lower with topical beta blockers compared with oral preparations, and I have not had any parents note any local side effects. Pyogenic Granuloma or Spitz Nevus? Pyogenic granulomas are misnamed because they are neither infectious nor granulomas. They are common benign vascular tumours that may occur as the result of minor trauma. They are often pedunculaed and have a tendency to bleed easily. Parents often resort to having the child wear a bandage constantly. Patients often present to the office with ‘the bandaid sign’ which aids in diagnosis and differentiation from other red papules. Recent studies indicate topical imiquimod is an easier and less invasive treatment option than the gold standard treatment of curettage and electrocautery previously employed (4,5). Parents should be counseled about the risk of irritation with this medication. If irritation occurs, the patient should be instructed to stop the treatment until the irritation resolves. Thereafter, they can reintiate treatment but at a lower frequency. Based on the results achieved with hemangiomas, topical timolol can be considered as an option for pyogenic granulomas.With this treatment the patient does not experience the irritation that can occur with imiquimod. My experience is that topiccal timolol may be less effective, but further research is needed to define the best treatment. If a paedictrician removes a pygenic granuloma (curretage) the specimen should be sent to the lab because Spitz nevi can at times mimic pyogneic granuloma. In the situation where the clinician is not sure of the diagnosis (Spitz nevi versus pyogenic granuloma versus other) then the biopsy specimen should be sent to an experienced dermatopathologist because Spitz nevi can be mistaken for melanoma under the microscope. Although Spitz nevi are considered to be benign, their true prognosis and risk is not known and some dermatologists prefer to remove the lesion while others feel comfortable with close observation of a typical spitz nevus. Molloscum Contagiosum This viral infection is characterized by pearly, dome-shaped papules. Koebnerization (papules growing in a line of trauma) may provide a clue to the papules being molluscum because they often grow in a line due to scratching. Secondary redness usually indicates an inflammatory reaction rather than infection. “I like to see a bit of inflammation (redness) in the area. I tell my patients that this is a good sign that the body is trying to rid itself of the 3 COPYRIGHT PULSUS GROUP INC. – DO NOT COPY CANADIAN PAEDIATRIC SOCIETY – 89th Annual Conference infection,” said Dr Bergman. The inflammatory response can induce a secondary eczema that can camouflage the molluscum. Cure the molluscum and the eczema will resolve. However, if the eczema is significant then treating the inflammation associated with the eczema is important even though the anti-inflammatory effects of the medications may allow a temporary flare of the molluscum. There is not one preferred evidencedbased treatment for molluscum, as well, not treating is always an option. Some advocate curettage with good cure rates, but this process increases patient anxiety and may increase the risk of scarring. The use of topical cantharidin (6) or imiquimod (7) may well be easier to perform and be more pleasant for the patient and family, Dr Bergman indicated; in one study of cantharidin, the cure rate was approximately 90% with one or two treatments. Patients using cantharidin may develop blisters because it is an extract of blister beetle; however, if applied sparingly and washed off after 4 h the risk is low. Parents of patients with a greater degree of pigment in their skin should be counselled that they will have a higher rate of postinflammatory hyperpigmentation. I do not recommend the use of cantharidin on the face, neck or groin due to a higher tendency for larger blisters in this area. Wart or Epidermal Nevus? A wart is caused by one of more than 200 human papillomaviruses transmitted through direct contact or auto-inoculation. Children most frequently develop common warts (verruca vulgaris) on the feet or hands, or flat warts, which typically occur on the face. Because some warts may resolve with time, a decision to initiate treatment must take into account the efficacy of the proposed treatment, side effects including pain, likelihood of compliance, convenience and cost. A recent Cochrane analysis deemed salicylic acid the most efficacious treatment. If over-thecounter preparations are not effective, “I often use [a 50% concentration] in white petrolatum. You put a small amount on the wart and tape it up. It will induce maceration of the tissue…you need to warn the patient,” Dr Weinstein stated. Liquid nitrogen is less effective and, unless a numbing cream is administered first, is painful for children. Adolescents 4 are often able to tolerate it. Some practitioners have employed imiquimod (offlabel) for common warts. “I would not use it for plantar warts [because] I don’t think that the hyperkeratosis that builds up on the wart allows adequate penetration,” Dr Weinstein cautioned. Based on anecdotal reports, at least two studies have evaluated the efficacy of duct tape versus a regular occlusive dressing or cryotherapy for wart removal. In one of these, said Dr Weinstein, “all the warts that showed a response to duct tape did so by three weeks. So if parents want to use duct tape, I tell them use it [replaced weekly] for three weeks; if there is benefit, to continue until the wart is gone. If there is no benefit [by three weeks], it’s unlikely to be helpful.” Epidermal nevi are papillomatous and verrucous and can be mistaken for warts, Dr Weinstein remarked. “The problem is [an epidermal nevi] often has a latent onset, so while it’s destined to be there from birth it’s not always evident at birth....Often times we can reassure the family it’s not a wart, it’s a birthmark.” They tend to grow until the child is about school age. If bothersome, these benign lesions can be removed with laser, cryotherapy or excision. Bald, Brown and White Spots Nevi sebaceous are hairless, oval, salmoncoloured, greasy plaques that develop on the scalp or other areas of the head or neck. They may wax and wane (for example, are more prominent in infancy and at puberty) but never resolve completely on their own. It was once believed nevi sebaceous were associated with a 10% basal cell carcinoma in adulthood; however, most recent literature indicates the risk is likely less than 1% (8,9). They do have an increased risk of benign adnexal tumours of approximately 10% (9). Patients must be counselled to return for evaluation of any new bump on the plaque. For cosmetic reasons, many children with a nevus sebaceous want it removed by adolescence, at which time the procedure can be performed safely under local anesthesia. Cutis aplasia is differentiated from nevus sebaceous by its shiny, smooth, scarlike appearance. This type of lesion may require investigation if it is large (>3 cm) or situated on the neck/spine or midline, posterior or anterior to the vertex. Other signs for concern are concomitant abnormalities (hemangioma or vascular stain) or a ‘collarette’ of hair around the lesion, which suggests the possibility of neurocutaneous involvement. When a patient presents with a possible café au lait macule that has a history of being irritated or swollen then the clinician should try to elict Darier’s sign. Darier’s sign is when a hive appears in the brown area after rubbing frimly and it is diagnostic of a mastocytoma (mast cell disease). Mast cell disease is a continuum ranging from solitary local involvement to systemic disease. Fortunately the most common form is the solitary mastocytoma which presents with local lesional symptoms and the lesion generally involutes over time. More extensive cutaneous involvement may produce urticaria pigmentosa which is often isolated to the skin but can have systemic organ involvement. Patients should avoid known triggers that include heat, cold, stress, and certain foods and medications. In patients with multiple mastocytomas (urticaria pigmentosa) an epinephrine autoinjector should be prescribed as a precaution because it is possible to have a generalized degranulation of these mast cells. Among the many causes of white spots on the skin are tinea versicolor and vitiligo. Tinea versicolor often appears in a shawl distribution and produces a fine, wrinkled scale, Dr Bergman noted. Vitiligo generally has a symmetrical distribution and is well demarcated. In addition, vitiligo produces depigmentation while tinea versicolor lesions are hypopigmented. Similarly, pityriasis alba produces hypopigmented areas with fuzzy borders, he added. Tinea versicolor can be managed with topical or oral antifungals. A simpler and less expensive option to eliminate the causative pathogen, malassezia, is antifungal shampoo. It could be applied from the neck down, left for five minutes, then rinsed off; the treatment should be repeated daily for a week. New Methods Against Lice Head lice infestation causes embarrassment, distress, exclusion from school or daycare, and social stigma. Local treatments now available include insecticides (permethrin [eg, Nix (Insight Pharmaceuticals, LLC, USA)], synergized pyrethrin [eg, R&C Shampoo (Block Drug Company, Inc, USA)] and malathion) and noninsecticidal/physical modalities. Oral COPYRIGHT PULSUS GROUP INC. – DO NOT COPY CANADIAN PAEDIATRIC SOCIETY – 89th Annual Conference ivermectin is widely used elsewhere but is difficult to obtain in Canada. Insecticide resistance is developing among many lice strains (10), which in addition to incomplete ovicidal activity by these agents may lead to treatment failures. Newer over-the-counter medications such as isopropyl myristate in combination with cyclomethicone (eg, Resultz [Nycomed Canada Inc, Canada]) or dimeticone (100cST 50% w/w, eg, NYDA [PediaPharm Inc, Canada] – approved by Health Canada in 2011) kill lice by physical mechanisms (dehydration or asphyxiation) rather than neurotoxicity, Dr Weinstein indicated, and in comparative studies these have been more effective than permethrin at eradicating both adult lice and larvae. “They may well address the resistance issues we have encountered and concerns about pesticides,” she added. As with insecticides, two treatments seven to 10 days apart followed by fine-combing help ensure complete eradication of lice and eggs. Home remedies, such as mayonnaise, tea tree oil and coconut oil, are not supported by current evidence. Similarly, given that lice need a regular blood meal, there is little evidence that environmental decontamination with pesticides is necessary or helpful. Washing clothes, toys and bedding in hot water, or storing items in an occlusive bag for several days to weeks is likely equally effective. If patients or parents still complain of symptoms, clinicians should consider several possibilities including treatment failure due to resistant lice or poor compliance with the regimen, or reinfestation. In addition, Dr Weinstein commented, think about other diagnoses. “There are lots of causes of itchy scalp, with atopic dermatitis being one of the major ones.” Complicated Eczema Patients with eczema may experience secondary infection with pathogens such as Staphylococcus or Streptococcus (impetigo) or herpes simplex. The risk is heightened by the loss of the skin’s barrier function in eczema. Impetiginized eczema may have more subtle signs and symptoms than impetigo alone, Dr Weinstein remarked. “You can get a thick or yellow crust, but sometimes it’s just a worsening of the eczema. And patients tell you their typical therapies don’t work any more. Of course they can be systemically unwell but that is uncommon.” Topical antibiotics and bleach baths (1/2 cup of household bleach in a 1/4 standard-sized tub of water, three times weekly) can help address bacterial infection and colonization in patients with eczema. “I don’t use [bleach baths] first line. I use them in kids who repeatedly get impetiginized with their eczema and I use it in hard to control eczema,” Dr Weinstein said. Infection with herpes simplex virus can cause extensive lesions in patients with eczema. The lesions are very similar in appearance and typically grouped. “It can have a high degree of morbidity and needs to be recognized and treated properly,” Dr Weinstein stressed. Depending on the patient’s condition and the availability of follow-up, oral or intravenous acyclovir may be considered. If the eczema herpeticum involves the nasal tip or the eye, an ophthalmologist referral may be needed due to the risk of herpes keratitis. Barrier Repair In addition to corticosteroids and calcineurin inhibitors, clinicians may also consider a prescription-strength barrierrepair emulsion to help restore adequate ceramides to the skin (eg, EpiCeram [PediaPharm Inc, Canada]). There are also some emollients that aim to enhance ceramide content of the skin in the management of eczema (eg, CeraVe [Coria Laboratories, USA], Restoraderm [Galderma, Switzerland]). “The calcineurin inhibitors and the cortisones are anti-inflammatory and anti-itch. I like to think of them as the fire extinguisher when you have a flare of eczema,” Dr Weinstein remarked. “[The barrier repair emulsion – EpiCeram] works in a different way. It’s trying to temporarily repair the barrier defect, which is one of the main problems in eczema. If you can repair the barrier then you don’t get as many irritants in to incite an inflammatory response and you’ll prevent water from getting out.” She suggested that this product may be effective on mild or thin eczema patches and/or as part of a multi-agent regimen. “These classes can all be mixed. You can, for example, use a calcineurin inhibitor on the face and a corticosteroid on the body. You can also use [the barrier repair product] at the beginning of a flare, and if it doesn’t control it you can advance to a calcineurin inhibitor.” The new therapy may be offered to patients or parents who have concerns about steroid use; however, said Dr Weinstein, “If the patient has rip-roaring eczema covering a lot of their body I am probably going to push pretty hard for them to get it under control rapidly with a corticosteroid, and then longer term they can look at the other agents when there is less inflammation.” DISCLOSURES: Dr Weinstein has acted as a consultant and/or speaker for Pediapharm, Nycomed and Galderma. References 1. Leaute-Labreze C, Dumas de la Roque E, Hubiche T, et al. Propranolol for severe hemangiomas of infancy. N Engl J Med 2008;358:2649-51. 2. Sans V, de la Roque ED, Berge J, et al. Propranolol for severe infantile hemangiomas: Follow-up report. Pediatrics 2009;124:e423-31. 3. Pope E. Topical timolol gel for hemangiomas. A pilot study. Arch Dermatol 2010;146:564-5. 4. Glencoglan G, Inanir I, Gunduz K. Pyogenic granuloma in two children successfully treated with imiquimod 5% cream. Pediatr Dermatol 2009;26:366-8. 5. Tritton SM, Smith S, Wong LC et al. Pyogenic granuloma in ten children treated with topical imiquimod. Pediatr Dermatol 2009;26:269-72. 6. Silverberg NB, Sidbury R, Mancini AJ. Childhood molluscum contagiosum: Experience with cantharidin therapy in 300 patients. J Am Acad Dermatol 2000;43:503-7. 7. Hanna D, Hatami A, Powell J, et al. A prospective randomized trial comparing the efficacy and adverse effects of four recognized treatments of molluscum contagiosum in children. Pediatr Dermatol 2006;23:574-9. 8. Cribier B, Scrivener Y, Grosshans E. Tumors arising in nevus sebaceous. A review of 596 cases. J Am Acad Dermatol 2000;42:263-8. 9. Rosen H, Schmidt B, Lam HP et al. Management of nevus sebaceous and the risk of basal cell carcinoma: An 18-year review. Pediatr Dermatol 2009;26:676-81. 10. Marcoux D, Palma KG, Kaul N, et al. Pyrethroid pediculicide resistance of head lice in Canada evaluated by serial invasive signal amplification reaction. J Cutan Med Surg 2010;14:115-8. 5